JPH10257893A5 - - Google Patents

Info

Publication number
JPH10257893A5
JPH10257893A5 JP1997066981A JP6698197A JPH10257893A5 JP H10257893 A5 JPH10257893 A5 JP H10257893A5 JP 1997066981 A JP1997066981 A JP 1997066981A JP 6698197 A JP6698197 A JP 6698197A JP H10257893 A5 JPH10257893 A5 JP H10257893A5
Authority
JP
Japan
Prior art keywords
antibody
chain
region
amino acid
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997066981A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550947B2 (ja
JPH10257893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP06698197A external-priority patent/JP4550947B2/ja
Priority to JP06698197A priority Critical patent/JP4550947B2/ja
Priority to AU59420/98A priority patent/AU751948B2/en
Priority to AT98105047T priority patent/ATE268382T1/de
Priority to CA002226400A priority patent/CA2226400C/en
Priority to ES98105047T priority patent/ES2219802T3/es
Priority to EP98105047A priority patent/EP0882794B1/en
Priority to DE69824234T priority patent/DE69824234T2/de
Publication of JPH10257893A publication Critical patent/JPH10257893A/ja
Publication of JPH10257893A5 publication Critical patent/JPH10257893A5/ja
Publication of JP4550947B2 publication Critical patent/JP4550947B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP06698197A 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体 Expired - Lifetime JP4550947B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP06698197A JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体
ES98105047T ES2219802T3 (es) 1997-03-19 1998-03-19 Anticuerpo contra el glangliosido gm2, injertado en la zona de determinacion de complementariedad humana (cdr).
AT98105047T ATE268382T1 (de) 1997-03-19 1998-03-19 MENSCHLICHE-ßCDR-GRAFTEDß-ANTIKÖRPER GEGEN GANGLIOSID GM2
CA002226400A CA2226400C (en) 1997-03-19 1998-03-19 Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
AU59420/98A AU751948B2 (en) 1997-03-19 1998-03-19 Human complementarity determining region (CDR)-grafted antibody to ganglioside GM2
EP98105047A EP0882794B1 (en) 1997-03-19 1998-03-19 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
DE69824234T DE69824234T2 (de) 1997-03-19 1998-03-19 Menschliche"CDR-grafted"-Antikörper gegen Gangliosid GM2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06698197A JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体

Publications (3)

Publication Number Publication Date
JPH10257893A JPH10257893A (ja) 1998-09-29
JPH10257893A5 true JPH10257893A5 (https=) 2005-02-24
JP4550947B2 JP4550947B2 (ja) 2010-09-22

Family

ID=13331716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP06698197A Expired - Lifetime JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体

Country Status (7)

Country Link
EP (1) EP0882794B1 (https=)
JP (1) JP4550947B2 (https=)
AT (1) ATE268382T1 (https=)
AU (1) AU751948B2 (https=)
CA (1) CA2226400C (https=)
DE (1) DE69824234T2 (https=)
ES (1) ES2219802T3 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407734B1 (en) 1994-10-31 2002-06-18 Nec-Mitsubishi Electric Visual Systems Corporation Power supply system capable of reducing power consumption during interruption of an external input signal given to an operating circuit
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
EP1176195B1 (en) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US6693176B1 (en) 1999-07-23 2004-02-17 University Of Massachusetts Antitumor antibodies, proteins, and uses thereof
WO2001023431A1 (fr) * 1999-09-30 2001-04-05 Kyowa Hakko Kogyo Co., Ltd. Derives d'anticorps contre le ganglioside gm2
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
AU2016204535C1 (en) * 2000-04-12 2017-02-23 Laboratoire Français Du Fractionnement Et Des Biotechnologies Anti-D monoclonal antibodies
JP2001299349A (ja) * 2000-04-19 2001-10-30 Suntory Ltd 新規組換え型抗体とそのｃｄｒのアミノ酸配列およびそれをコードする遺伝子
ES2639222T5 (es) * 2000-10-06 2023-11-24 Kyowa Kirin Co Ltd Células que producen unas composiciones de anticuerpo
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
CA2451854A1 (en) * 2001-06-28 2003-01-09 Kyowa Hakko Kogyo Co., Ltd. Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
US7935338B2 (en) 2001-12-11 2011-05-03 University Of Massachusetts Antibodies to treat cancer
US7708999B2 (en) 2001-12-28 2010-05-04 Kyowa Hakko Kirin Co., Ltd. Remedies for arthritis
CA2481920A1 (en) 2002-04-09 2003-10-16 Kyowa Hakko Kogyo Co., Ltd. Antibody composition-containing medicament
US20040115204A1 (en) 2002-12-11 2004-06-17 Fanger Gary R. Antibodies to treat cancer
US20090028877A1 (en) * 2003-10-09 2009-01-29 Shigeru Iida Antibody Composition Specifically Binding to Ganglioside Gm
US7691810B2 (en) 2003-10-09 2010-04-06 Kyowa Hakko Kirin Co., Ltd Method of producing recombinant antithrombin III composition
WO2008090960A1 (ja) 2007-01-24 2008-07-31 Kyowa Hakko Kirin Co., Ltd. ガングリオシドgm2に特異的に結合する遺伝子組換え抗体組成物
FR2953841B1 (fr) * 2009-12-16 2011-12-30 Centre Nat Rech Scient Anticorps diriges contre le recepteur de la transferrine et leurs utilisations pour l'immunotherapie des tumeurs qui dependent du fer
ES2602971T3 (es) 2010-03-02 2017-02-23 Kyowa Hakko Kirin Co., Ltd. Composición de anticuerpo modificado
WO2014088040A1 (ja) 2012-12-06 2014-06-12 国立大学法人 金沢大学 中皮腫の治療方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105618C (en) * 1992-09-07 2009-11-03 Kazuyasu Nakamura Humanized antibodies to ganglioside gm2

Similar Documents

Publication Publication Date Title
JPH10257893A5 (https=)
Daugherty et al. Polymerase chain reaction facilitates the cloning, CDRgrafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins
KR100239607B1 (ko) 인화 항체 및 이것의 사용 방법
JP3525221B2 (ja) 免疫抑制剤
JPH10114795A (ja) Ｔｎｆ結合タンパク質
WO2000058480A1 (en) Novel cytidine deaminase
JP3255699B2 (ja) ヒトＩＬ−２レセプターγ鎖分子
JP4550947B2 (ja) ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体
CN112521501A (zh) Gipr抗体及其与glp-1的融合蛋白质，以及其药物组合物和应用
JP3614183B2 (ja) ヒトインターロイキン−６に対する再構成ヒト抗体
KR100277769B1 (ko) 항-파스 재조합 항체 및 이에 대한 디엔에이
CN114057878A (zh) 降低单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法
JP3231262B2 (ja) ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体
JP2001500013A (ja) ＨＴ▲下ｍ４▼、治療およびアッセイ方法、アゴニストおよびアンタゴニスト
JP3024311B2 (ja) Ｉｌ−２受容体重鎖に結合するポリペプチド
AU2023272924A1 (en) Klrb1 binding agents and methods of use thereof
JP2009526535A (ja) 新規ｃｃケモカインアンタゴニスト
CA2497937A1 (en) Nuclear factor of activated t cells receptor
JP4059404B2 (ja) 甲状腺機能を刺激する活性を持つ抗体
WO2003057252A1 (en) Human mast cell-expressed membrane proteins
WO1997031110A1 (fr) Molecule de la famille des genes de transfert f, polynucleotide codant pour cette molecule et anticorps actif contre cette molecule
JPH10324699A (ja) 抗ヒトＦａｓヒト化抗体
WO2026017189A2 (zh) 抗il-31抗体、其药物组合物及用途
JP2009513124A (ja) 新規ｃｘｃケモカインアンタゴニスト
JP3844519B2 (ja) 免疫抑制剤